Back to top
more

Quest Diagnostics (DGX)

(Delayed Data from NYSE)

$135.42 USD

135.42
1,015,491

-2.13 (-1.55%)

Updated Apr 25, 2024 04:00 PM ET

After-Market: $135.45 +0.03 (0.02%) 6:06 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 39% (154 out of 251)

Industry: Medical - Outpatient and Home Healthcare

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for DGX

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Quest Diagnostics Incorporated falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 686 315 872 1,158 1,192
Receivables 1,210 1,195 1,438 1,520 1,063
Notes Receivable 0 0 0 0 0
Inventories 190 192 208 223 123
Other Current Assets 286 196 223 157 112
Total Current Assets 2,372 1,898 2,741 3,058 2,490
Net Property & Equipment 1,816 1,766 1,707 1,627 1,453
Investments & Advances 135 132 141 521 482
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 8,899 8,312 8,262 8,040 7,740
Deposits & Other Assets 198 144 163 176 160
Total Assets 14,022 12,837 13,611 14,026 12,843
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 1,359 1,396 1,600 1,633 1,041
Current Portion Long-Term Debt 303 2 2 2 804
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 0 0 0 0 0
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 1,815 1,551 1,753 1,776 1,990
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 4,410 3,978 4,010 4,013 3,966
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 876 812 792 847 711
Minority Interest (Liabilities) 76 77 79 82 76
Total Liabilities 7,680 6,907 7,128 7,217 7,156
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 2 2 2 2 2
Capital Surplus 2,320 2,295 2,260 2,841 2,722
Retained Earnings 8,825 8,290 7,649 9,303 8,174
Other Equity 21 16 25 29 7
Treasury Stock 4,826 4,673 3,453 5,366 5,218
Total Shareholder's Equity 6,342 5,930 6,483 6,809 5,687
Total Liabilities & Shareholder's Equity 14,022 12,837 13,611 14,026 12,843
Total Common Equity 6,342 5,930 6,483 6,809 5,687
Shares Outstanding 112.40 113.80 122.60 134.70 134.70
Book Value Per Share 56.42 52.11 52.88 50.55 42.22

Fiscal Year End for Quest Diagnostics Incorporated falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 686 143 126 175
Receivables NA 1,210 1,281 1,235 1,254
Notes Receivable NA 0 0 0 0
Inventories NA 190 184 184 190
Other Current Assets NA 286 207 188 195
Total Current Assets NA 2,372 1,815 1,733 1,814
Net Property & Equipment NA 1,816 1,830 1,814 1,795
Investments & Advances NA 135 130 135 128
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 8,899 8,951 8,980 8,318
Deposits & Other Assets NA 198 149 152 150
Total Assets NA 14,022 13,482 13,425 12,794
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 1,359 1,157 1,201 1,198
Current Portion Long-Term Debt NA 303 304 518 2
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 0 0 0 0
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 0 0 0 0
Total Current Liabilities NA 1,815 1,618 1,875 1,355
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 4,410 3,946 3,777 3,975
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 874 901 809
Minority Interest (Liabilities) NA 76 76 77 77
Total Liabilities NA 7,680 7,019 7,138 6,706
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 2 2 2 2
Capital Surplus NA 2,320 2,302 2,284 2,266
Retained Earnings NA 8,825 8,711 8,566 8,412
Other Equity NA 21 18 22 20
Treasury Stock NA 4,826 4,570 4,587 4,612
Total Shareholder's Equity NA 6,342 6,463 6,287 6,088
Total Liabilities & Shareholder's Equity NA 14,022 13,482 13,425 12,794
Total Common Equity 0 6,342 6,463 6,287 6,088
Shares Outstanding 111.00 112.40 112.40 112.20 112.00
Book Value Per Share 0.00 56.42 57.50 56.03 54.36